CH Biotech R&D CoTPE:6534 +0.11%84 Interest Coverage is 11.74 as of Dec. 2025, which is 63% below its 10-year median of 32.03. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 199 Agriculture companies, CH Biotech R&D Co ranks better than 80.4% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. CH Biotech R&D Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$42 Mil. CH Biotech R&D Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-4 Mil.
CH Biotech R&D Co's interest coverage for the quarter that ended in Dec. 2025 was 11.74.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for CH Biotech R&D Co's Interest Coverage or its related term are showing as below:
TPE:6534'
s Interest Coverage Range Over the Past 10 Years
Min: 6.38 Med: 32.03 Max: 45.51
Current: 37.39
TPE:6534's Interest Coverage is ranked better than 80.4% of 199
companies
in the Agriculture industry
Industry Median: 7.3
vs TPE:6534: 37.39
CH Biotech R&D Co (TPE:6534) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
CH Biotech R&D Co Interest Coverage Related Terms
CH Biotech R&D Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for CH Biotech R&D Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TPE:6534 vs CTVA, CF, MOS: Interest Coverage Comparison
For the Agricultural Inputs subindustry, CH Biotech R&D Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CH Biotech R&D Co Interest Coverage vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where CH Biotech R&D Co's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CH Biotech R&D Co (TPE:6534) has a Interest Coverage of 11.74 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CH Biotech R&D Co and its competitors. This is 63% below median its historical median of 32.03. Over the past decade, CH Biotech R&D Co's Interest Coverage has ranged from 6.38 to 45.51. According to the industry distribution chart, CH Biotech R&D Co ranks #39 out of 199 companies in the Agriculture industry, placing it in the top 19.6%.
Is CH Biotech R&D Co's Interest Coverage too high?
CH Biotech R&D Co's current Interest Coverage of 11.74 is 63% below median its 10-year median of 32.03. Over the past 10 years, this metric has ranged from a low of 6.38 to a high of 45.51. The Agriculture industry median Interest Coverage is 7.30. CH Biotech R&D Co's value of 11.74 is 60.8% above this industry median. Based on the distribution chart, CH Biotech R&D Co ranks #39 out of 199 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's Interest Coverage compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #39 out of 199 companies for Interest Coverage. This places CH Biotech R&D Co in the top 20% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.30. CH Biotech R&D Co's value of 11.74 is 60.8% above this benchmark. Historically, CH Biotech R&D Co's own Interest Coverage has ranged from 6.38 to 45.51 over the past decade. While the company's 10-year median is 32.03 vs. the industry median of 7.30, CH Biotech R&D Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for an Agriculture company?
The median Interest Coverage among Agriculture companies is 7.30, based on 199 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CH Biotech R&D Co's current Interest Coverage of 11.74 is 60.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CH Biotech R&D Co and its competitors. For the Agriculture industry, the median Interest Coverage is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CH Biotech R&D Co's current Interest Coverage is 11.74, which is 63% below median its own 10-year median of 32.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$100.55, compared to a current price of NT$90.20 — trading 10.3% below its estimated fair value. The current Interest Coverage is 11.74, which is 63% below median its 10-year median of 32.03 and 60.8% above the Agriculture industry median of 7.30. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current Interest Coverage is 11.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?
Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued.
The current stock price of NT$90.20 is trading 10.3% below its estimated GF Value™ of NT$100.55.
GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.
Key valuation signals for TPE:6534:
Interest Coverage: 11.74 (63% below median its 10-year median of 32.03)
GF Value™: NT$100.55 vs. price of NT$90.20 (10.3% below fair value)
Industry Position: 60.8% above the Agriculture median (#39 of 199)
No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score
Get the complete analysis for TPE:6534
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6534 has been successfully added to your 
